Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yuji Masuta"'
Autor:
Takuto Nogimori, Yuta Nagatsuka, Shogo Kobayashi, Hirotomo Murakami, Yuji Masuta, Koichiro Suzuki, Yoshito Tomimaru, Takehiro Noda, Hirofumi Akita, Shokichi Takahama, Yasuo Yoshioka, Yuichiro Doki, Hidetoshi Eguchi, Takuya Yamamoto
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-13 (2024)
Abstract Background Liver transplant recipients (LTRs) are at a high risk of severe COVID-19 owing to immunosuppression and comorbidities. LTRs are less responsive to mRNA vaccines than healthy donors (HDs) or other immunosuppressed patients. However
Externí odkaz:
https://doaj.org/article/4b65897df7e54183a54aaaa12de9c513
Autor:
Hirotomo Murakami, Shokichi Takahama, Hirofumi Akita, Shogo Kobayashi, Yuji Masuta, Yuta Nagatsuka, Masaya Higashiguchi, Akira Tomokuni, Keiichi Yoshida, Hidenori Takahashi, Yuichiro Doki, Hidetoshi Eguchi, Nariaki Matsuura, Takuya Yamamoto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
CD8+ T cells affect the outcomes of pancreatic ductal adenocarcinoma (PDAC). Using tissue samples at pre-treatment to monitor the immune response is challenging, while blood samples are beneficial in overcoming this limitation. In this study, we meas
Externí odkaz:
https://doaj.org/article/d6000d047b4a44b790b96e68f5129a77
Autor:
Mai Komori, Takuto Nogimori, Amber L. Morey, Takashi Sekida, Keiko Ishimoto, Matthew R. Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F. Smith, Wataru Akahata
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Several vaccines have been widely used to counteract the global pandemic caused by SARS-CoV-2. However, due to the rapid emergence of SARS-CoV-2 variants of concern (VOCs), further development of vaccines that confer broad and longer-lasting
Externí odkaz:
https://doaj.org/article/3124fc90ff494ed297e7c6378d5060e4
Autor:
Shokichi Takahama, Sachiyo Yoshio, Yuji Masuta, Hirotomo Murakami, Ryotaro Sakamori, Shun Kaneko, Takashi Honda, Miyako Murakawa, Masaya Sugiyama, Masayuki Kurosaki, Yasuhiro Asahina, Tetsuo Takehara, Victor Appay, Tatsuya Kanto, Takuya Yamamoto
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Despite treatment, hepatitis B surface antigen (HBsAg) persists in patients with chronic hepatitis B (CHB), suggesting the likely presence of the virus in the body. CD8+ T cell responses are essential for managing viral replication, but their effect
Externí odkaz:
https://doaj.org/article/1d09105d328b4551aba7580d6b0d95b3
Autor:
Takuto Nogimori, Koichiro Suzuki, Yuji Masuta, Ayaka Washizaki, Mika Yagoto, Mami Ikeda, Yuki Katayama, Hidenori Kanda, Minoru Takada, Shohei Minami, Takeshi Kobayashi, Shokichi Takahama, Yasuo Yoshioka, Takuya Yamamoto
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Understanding the T-cell responses involved in inhibiting COVID-19 severity is crucial for developing new therapeutic and vaccine strategies. Here, we characterized SARS-CoV-2 spike-specific CD8+ T cells in vaccinees longitudinally. The BNT162b2 mRNA
Externí odkaz:
https://doaj.org/article/20503c38eef84e87874e6677201f3264
Autor:
Yuji Masuta, Shokichi Takahama, Takuto Nogimori, Saya Moriyama, Yoshimasa Takahashi, Takuya Yamamoto
Publikováno v:
iScience, Vol 25, Iss 10, Pp 105085- (2022)
Summary: Several cross-protective antibodies that recognize a broad range of influenza A virus (IAV) strains are known to have functions in virus elimination such as Fcγ receptor (FcγR)-effector function and neutralizing activity against the head r
Externí odkaz:
https://doaj.org/article/d46b953959d045d888ad922f93e1bb2a
Autor:
Hirotomo Murakami, Shokichi Takahama, Hirofumi Akita, Shogo Kobayashi, Yuji Masuta, Yuta Nagatsuka, Masaya Higashiguchi, Akira Tomokuni, Keiichi Yoshida, Hidenori Takahashi, Yuichiro Doki, Hidetoshi Eguchi, Nariaki Matsuura, Takuya Yamamoto
Publikováno v:
Frontiers in Immunology; 2024, p1-12, 12p
Autor:
Shokichi Takahama, Sachiyo Yoshio, Yuji Masuta, Hirotomo Murakami, Ryotaro Sakamori, Shun Kaneko, Takashi Honda, Miyako Murakawa, Masaya Sugiyama, Masayuki Kurosaki, Yasuhiro Asahina, Tetsuo Takehara, Appay, Victor, Tatsuya Kanto, Takuya Yamamoto
Publikováno v:
Frontiers in Immunology; 2023, p1-12, 12p
Autor:
Wataru Akahata, Takashi Sekida, Takuto Nogimori, Hirotaka Ode, Tomokazu Tamura, Kaoru Kono, Yoko Kazami, Ayaka Washizaki, Yuji Masuta, Rigel Suzuki, Kenta Matsuda, Mai Komori, Amber Morey, Keiko Ishimoto, Misako Nakata, Tomoko Hasunuma, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F Smith, Nobuaki Sato
SummaryBACKGROUNDVLPCOV-01 is a lipid nanoparticle-encapsulated self-amplifying RNA (saRNA) vaccine that expresses a membrane-anchored receptor-binding domain (RBD) derived from the SARS-CoV-2 spike protein.METHODSA phase 1 study of VLPCOV-01 was con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6b1fe5342cf73a4f57c79b7f62a5d9
https://doi.org/10.2139/ssrn.4309025
https://doi.org/10.2139/ssrn.4309025
Autor:
Takuto Nogimori, Koichiro Suzuki, Yuji Masuta, Mika Yagoto, Mami Ikeda, Yuki Katayama, Ayaka Washizaki, Hidenori Kanda, Minoru Takada, Shohei Minami, Takeshi Kobayashi, Shokichi Takahama, Yasuo Yoshioka, Takuya Yamamoto
Understanding the T-cell responses involved in inhibiting COVID-19 severity is crucial for developing new therapeutic and vaccine strategies. Here, we characterized SARS-CoV-2 spike-specific CD8+ T cells interacting with overlapping peptides on perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e54c9e378d239f80c5510d8fdc762b5b
https://doi.org/10.21203/rs.3.rs-1364513/v1
https://doi.org/10.21203/rs.3.rs-1364513/v1